Диссертация (1140154), страница 22
Текст из файла (страница 22)
2008;24:597–60742.Bolte HD, Ludwig B. Viral myocarditis: symptomatology, clinical diagnosis,and hemodynamics. In: Bolte H-D, ed. Viral heart disease. Berlin: SpringerVerlag, 1984:177-18743.Bouhour JB, Helias J, de Lajartre AY, et al. Detection of myocarditis duringthe first year after discovery of a dilated cardiomyopathy by endomyocardial137biopsy and gallium-67 myocardial scintigraphy: prospective multicentre Frenchstudy of 91 patients. Eur Heart J. 1988 May;9(5):520-844.Bowles NE, Ni J, Kearney DL et al.
Detection of viruses in myocardialtissues by polymerase chain reaction: evidence of adenovirus as a common causeof myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466 – 47245.Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosisofloneatrialfibrillation:30yearsfollow-upintheFraminghamstudy. JAMA.1985;254:3449-3453.46.Breinholt JP, Moulik M, Dreyer WJ, et al. Viral epidemiologic shift ininflammatory heart disease: the increasing involvement of parvovirus B19 in themyocardium of pediatric cardiac transplant patients.
J Heart Lung Transplant.2010;29:739–4647.Brisinda D, Sorbo AR, Venuti A et al. Anti-β-adrenoceptors autoimmunitycausing «idiopathic» arrhythmias and cardiomyopathy. Circ J. 2012; 76(6): 13455348.Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic micewith myocardial expression of tumor necrosis factor-alpha.
Circulation 1998;97:1375–138149.Caforio ALP, Calabrese F, Angelini A, et al. A prospective study of biopsyproven myocarditis: prognostic relevance of clinical and aetiopathogeneticfeatures at diagnosis. Eur Heart J. 2007;28:1326–133350.Caforio ALP, Goldman JH, Baig MK, et al. Cardiac autoantibodies in dilatedcardiomyopathybecomeundetectablewithdiseaseprogression.Heart1997;77:62–6751.Caforio ALP, Goldman JH, Haven AJ, et al. Circulating cardiacautoantibodies as markers of autoimmunity in clinical and biopsy-provenmyocarditis. Eur Heart J 1997;18:270–27552.Caforio AL, Goldman JH, Haven AJ, et al.
Evidence for autoimmunity tomyosin and other heart-specific autoantigens in patients with dilatedcardiomyopathy and their relatives. Int J Cardiol 1996;54:157-16313853.Caforio AL,Marcolongo R,Jahns R, et al. Immune-mediated andautoimmune myocarditis: clinical presentation, diagnosis and management.Heart Failure Reviews 2013; 18(6): 715-73254.Caforio AL, Pankuweit S, Arbustini E, et al; European Society of CardiologyWorking Group on Myocardial and Pericardial Diseases.
Current state ofknowledge on aetiology, diagnosis, management, and therapy of myocarditis: aposition statement of the European Society of Cardiology Working Group onMyocardial and Pericardial Diseases. Eur Heart J. 2013 Sep;34(33):2636-4855.Caforio AL, Vinci A, Iliceto S. Anti-heart autoantibodies in familial dilatedcardiomyopathy. Autoimmunity. 2008; 41:462–46956.Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy:microbiological and molecular biological aspects. Cardiovasc Res 2003;60:11–2557.Calabrese F, Valente M, Thiene G, et al.
Enteroviral genome in native heartsmay influence outcome of patients who undergo cardiac transplantation. DiagnMol Pathol 1999;8:39–4658.Canter CE, Simpson KP. Diagnosis and treatment of myocarditis in childrenin the current era. Circulation. 2014 Jan 7;129(1):115-28.59.Castellano G, Affuso F, Di Conza P et al. Myocarditis and dilatedcardiomyopathy: possible connections and treatments. J Cardiovasc Med2008;9:666–67160.Chow LH, Sears TD, McManus BM.
Intensivity of right ventricularendomyocardial biopsy in the diagnosis of myocarditis: whither the goldstandart? J Am Coll Cardiol 1989;13:Suppl A:253А. abstract61.CihakovaD, RoseNR.Pathogenesisof myocarditis anddilatedcardiomyopathy. Adv Immunol. 2008;99:95-11462.Cooper LT Jr. Myocarditis. N Engl J Med 2009;360:1526-38.63.Cooper LT, Baughman KL, Feldman AM et al. The Role of EndomyocardialBiopsy in the Management of Cardiovascular Disease: A Scientific StatementFrom the American Heart Association, the American College of Cardiology, and139the European Society of Cardiology. J of the American College of Cardiology2007; 50 (19): 1914–193164.Cooper LT, Berry GJ, Shabetai R, for the Multicenter Giant Cell MyocarditisStudy Group Investigators.
Idiopathic giant-cell myocarditis: natural history andtreatment. N Engl J Med. 1997;336:1860 –186665.Daly K, Monaghan M, Richardson P, et al. Significant incidence of muralthrombi in acute myocarditis—indications for early anticoagulation (abstract). JAm Coll Cardiol 1983;1:58466.Daly K, Richardson PJ, Olsen EG et al. Acute myocarditis. Role ofhistological and virological examination in the diagnosis and assessment ofimmunosuppressive treatment.
Br Heart J 1984;51:30-3567.Dambrin G, Laissy JP, Serfaty JM et al. Diagnostic value of ECG-gatedmultidetector computed tomography in the early phase of suspected acutemyocarditis. A preliminary comparative study with cardiac MRI. Eur Radiol.2007; 17(2): p. 331-8Dandel M, Wallukat G, Potapov E, Hetzer R.
Role of β1-adrenoceptor68.autoantibodies in the pathogenesis of dilated cardiomyopathy. Immunobiology.2012 May;217(5):511-2069.De Asmundis C, Sorgente A, Brugada P. Atrial flutter in normal heart couldbe first manifestation of Brugada syndrome. Acta Cardiol. 2012; 67(1): 97-10070.Dec GW. Introduction to clinical myocarditis. In: Cooper LT, ed.Myocarditis: From Bench to Bedside. New Yersey: Humana Press; 2003:257–28171.Dec GW, Palacios IF, Fallon JT et al. Active myocarditis in the spectrum ofacute dilated cardiomyopathies: clinical features, histologic correlates, andclinical outcome. N Engl J Med. 1985;312:885– 89072.Dec GW, Palacios I, Yasuda T, et al.
Antimyosin antibody cardiac imaging:its role in the diagnosis of myocarditis. J Am Coll Cardiol. 1990;16:97–10473.de la Chapelle C.E., Kossmann C.E. Myocarditis. Circulation 1954Nov;10(5):747-76514074.Dello Russo A, Pieroni M, Santangeli P et al. Concealed cardiomyopathies incompetitive athletes with ventricular arrhythmias and an apparently normal heart:role of cardiac electroanatomical mapping and biopsy.
Heart Rhythm. 2011Dec;8(12):1915-2275.Dennert R., Crijns H.L., Heymans S. Acute viral myocarditis.Eur. Heart J2008; 29: 2073–208276.Doolan A., Langlois N., Semsarian C. Causes of sudden cardiac death inyoung Australians. Med J Aust 2004;180:110 – 11277.Drago F, Mazza A, Gagliardi MG et al.
Tachycardias in children originatingin the right ventricular outflow tract: lack of clinical features predicting thepresence and severity of the histopathological substrate. Cardiol Young. 1999;9(3): p. 273-978.Drory Y., Turetz Y., Hiss Y., et al. Sudden unexpected death in persons lessthan 40 years of age. Am J Cardiol 1991;68:1388 – 139279.ElammC, FairweatherD, CooperLT.Pathogenesis anddiagnosisof myocarditis. Heart. 2012 Jun;98(11):835-4080.Enders G, Dotsch J, Bauer J, et al. Life-threatening parvovirus B19associated myocarditis and cardiac transplantation as possible therapy: two casereports. Clin Infect Dis 1998;26:355-35881.Eriksson U, Penninger JM.
Autoimmune heart failure: new understanding ofpathogenesis. Int J Biochem Cell Biol 2005; 37:27–3282.Eriksson U, Penninger JM, Kopf M. Mechanisms of autoimmune heartdisease. Drug Discov Today 2004; 1:283–288Evans W, Swann P. Lone auricular fibrillation. Br Heart J., 1954; 16(2): р.83.189–19484.Fabre A., Sheppard M.N. Sudden adult death syndrome and other nonischaemic causes of sudden cardiac death: a UK experience. Heart 2005;92:316 –32085.Fairweather D, Kaya Z, Shellam G, et al. From infection to autoimmunity. JAutoimmun 2001; 16:175–186141Feldman A. M., McNamara D.
Myocarditis. N Engl J Med 2000;343:1388 –86.139887.Felix SB, Staudt A, Landsberger M, et al. Removal of cardiodepressantantibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol.2002;39:646 – 65288.Felker GM, Boehmer JP, Hruban RH, et al. Echocardiographic findings infulminant and acute myocarditis. J Am Coll Cardiol 2000;36:227-23289.Felker G.M., Hu W., Hare J.M., et al. The spectrum of dilatedcardiomyopathy: the Johns Hopkins experience with 1,278 patients. Medicine(Baltimore) 1999;78:270 - 28390.Felker GM, Thompson RE, Hare JM et al. Underlying causes and long-termsurvival in patients with initially unexplained cardiomyopathy. N Engl J Med.2000;342:1077–108491.Fenoglio Jr JJ, Ursell PC, Kellogg CF, et al. Diagnosis and classification ofmyocarditis by endomyocardial biopsy.
N Engl J Med 1983;308:12-1892.Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magneticresonance in myocarditis: A JACC White Paper. J Am Coll Cardiol2009;53:1475-148793.Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast mediaenhancedmagnetic resonance imaging visualizes myocardial changes in the course of viralmyocarditis. Circulation 1998;97:1802-180994.Frustaci A, Caldarulo M, Buffon A, et al. Cardiac biopsy in patients with"primary" atrial fibrillation. Histologic evidence of occult myocardial diseases.Chest.
1991; 100(2): р. 303-695.Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrialbiopsies in patients with lone atrial fibrillation. Circulation. 1997; 96(4): р. 1180496.Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy foractive lymphocytic myocarditis: virological and immunologic profile ofresponders versus nonresponders. Circulation 2003;107:857–86314297.Frustaci A, Francone M, Petrosillo N, Chimenti C. High prevalence ofmyocarditis in patients with hypertensive heart disease and cardiac deterioration.Eur J Heart Fail. 2013; 15(3):р.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
